A Healthcare Partner of Choice

New Marketlink Pharmaceutical Corporation (NMPC), was borne out of the marketing and distribution expertise of Marketlink International Corporation (MIC). The company has made significant steps in building and strengthening its position in the Philippine pharmaceutical industry leading to a significant growth of its business over almost one and a half decades.

Today, the new company, NMPC, fueled and propelled by the holding Company, TAO Corporation, is poised to undertake bold moves to further establish the new company as a respected leader in the pharmaceutical industry and become a valuable component of TAO Corporation’s mission of building communities and people.

NMPC, which began its commercial operations in December 2006, took over and continued on the old company’s specialty of importation, sales, promotion and distribution of a diverse specialty line of pharmaceutical and healthcare products.

With enhanced strategies to boost competitiveness, renewed focus on performance, and a passion to serve its customers, NMPC is ready to take on the challenges of the future.

People

The people of New Marketlink, at all levels and at all times, continue to uphold and lives out the values that give the company its heart and soul. The image of the company we project in our day-to-day operations is an outward manifestation of an inward personality --- shaped by Filipino tradition and conduct chosen by New Marketlink to be important.

While others rely only on product quality, New Marketlink trusts and counts on its people.

New Marketlink believes in getting close and staying close to its customers by giving them what they reasonably want and need, winning customers from competitors and keeping them.

We create commitment to customer service at every level of our organization; focusing employees’ efforts on giving customers excellent service.

Its management and staff have years of outstanding track record in the field of pharmaceutical marketing. New Marketlink employees proactively respond to the needs of the pharmaceutical industry by networking with various reputable medical organizations and associations on their requirements and on current pharmaceutical trends.

Manpower deployment of 120 field force calling on more than 15,300 physicians ensures the widest geographical coverage possible.

Divisionalized organization and exclusive group by volume / specialty line allows more flexibility in terms of handling products without any conflict and give focus on each product, providing better market share for the partner principal and comprehensive information for the medical practitioners.

Its management’s many years of success in developing respectable market share for its principal is proven by the number of companies it has started which are now firmly established and occupying leading positions in the local pharmaceutical industry.

Organization

Amado T. Tadena – Chairman & CEO
Oscar J. Aragon – President
Francis Z. Gomez, MD – Chief Operating Officer
Edgardo V. Regodon – New Business Research and Regulatory Affairs Manager
Jose P. Ancheta, Jr. – Marketing & Sales Director
Raul Ma. F. Anonas – Chief Finance Officer
Mateo Grigo S. Villenas – Supply Chain Manager
Maria Milagros B. Estrada – HR & Admin. Manager
Myra de Asis – Accounting Manager

Principals

• TEVA Pharmaceutical Industries Ltd.
  
• NOVARTIS Vaccines 
• ROWA Pharmaceuticals Ltd.
  
• BRACCO Imaging Spa
  
• NEWPORT Pharmaceuticals Ltd.
  
• PHARMACHEMIE BV
  
• HOE Pharmaceuticals SDN. DHD
  
• APOGEPHA Arznemittel GmBH
  
• NIPPON Shinyaku Co. LTD.
  
• PHARMAZEUTISCHE FABRIK MONTAVIT GmBH
  
• PHIL-INT’L CO., LTD.
  
• KEDRION (Sclavo)

Sub-distributor: Metro Drug, Incorporated

 

 

back to top